Statin-Associated Muscular and Renal Adverse Events: Data Mining of the Public Version of the FDA Adverse Event Reporting System

Abstract

OBJECTIVE Adverse event reports (AERs) submitted to the US Food and Drug Administration (FDA) were reviewed to assess the muscular and renal adverse events induced by the administration of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) and to attempt to determine the rank-order of the association. METHODS After a revision… (More)
DOI: 10.1371/journal.pone.0028124

Topics

2 Figures and Tables

Cite this paper

@inproceedings{Sakaeda2011StatinAssociatedMA, title={Statin-Associated Muscular and Renal Adverse Events: Data Mining of the Public Version of the FDA Adverse Event Reporting System}, author={Toshiyuki Sakaeda and Kaori Kadoyama and Yasushi Okuno}, booktitle={PloS one}, year={2011} }